Veterinary Medicines

Feligen CRP lyofilizát a rozpúšťadlo na injekčnú suspenziu

Authorised
  • Feline panleucopenia virus, Live
  • Felid herpesvirus 1, Live
  • Feline calicivirus, Live
Download as PDF

Product identification

Medicine name:
Feligen CRP lyofilizát a rozpúšťadlo na injekčnú suspenziu
Active substance:
  • Feline panleucopenia virus, Live
  • Felid herpesvirus 1, Live
  • Feline calicivirus, Live
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Feline panleucopenia virus, Live
    3.70
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Felid herpesvirus 1, Live
    5.00
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
  • Feline calicivirus, Live
    4.60
    log10 50% cell culture infectious dose
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cat
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AD04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Slovakia
Available in:
  • Slovakia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 97/210/94-S
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Slovak (PDF)
Published on: 27/02/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."